PharmaZen forecasts 44% jump in 2018 sales as new plant allows toll processing

PharmaZen forecasts 44% jump in 2018 sales as new plant allows toll processing
Jonathan Underhill
By Jonathan Underhill May 16 (BusinessDesk) - PharmaZen, a Christchurch-based manufacturer of plant and animal-based health supplements, is forecasting a 44 percent increase in sales this year and a jump in earnings as the company brings a new plant online. Turnover at its Waitaki Biosciences operating division is forecast to rise to $10.5 million this year from $7.3 million in 2017, according to a presentation to shareholders at their annual meeting this month. Earnings before interest, tax, depreciation and amortisation is seen rising t...